AI assistant
Coloplast — Director's Dealing 2017
Nov 16, 2017
3358_rns_2017-11-16_acb634b0-8650-4c7f-af5e-4d24861d5ed0.pdf
Director's Dealing
Open in viewerOpens in your device viewer
C
Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Urology Care
Nasdaq Copenhagen
16 November 2017
Coloplast A/S
Holtedam 1
3050 Humlebaek
Denmark
Tel: +45 4911 1111
www.coloplast.com
CVR-nr. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns the exercise of share options (purchase of shares).
| Name | Lars Rasmussen |
|---|---|
| Reason | CEO |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Share options |
| Transaction | Share option exercise (purchase of shares) |
| Trade date | 16 November 2017 |
| Market | NASDAQ Copenhagen |
| Number | 58,557 |
| Transaction value per share in DKK | 294.36 |
| Transaction value in DKK | 17,236,838.52 |
Calculation of share price:
When calculating the share price in connection with exercise of share options the purchase price is based on the strike price. The strike price is the share price at the grant date.
Kind regards,
Coloplast A/S
Anne-Sofie Søegaard
This information is available in Danish and in English, in case of doubt the Danish version prevails.
For further information: Anne-Sofie Søegaard, tel.: +45 4911 1924